...
首页> 外文期刊>Annals of surgical oncology >Short- and Long-Term Outcomes of Patients Requiring Gastrectomy During Cytoreductive Surgery and Intraperitoneal Chemotherapy for Lower-Gastrointestinal Malignancies: A Propensity Score-Matched Analysis
【24h】

Short- and Long-Term Outcomes of Patients Requiring Gastrectomy During Cytoreductive Surgery and Intraperitoneal Chemotherapy for Lower-Gastrointestinal Malignancies: A Propensity Score-Matched Analysis

机译:需要在细胞功能性手术和腹腔内化疗期间需要胃切除的患者的短期和长期结果,用于低胃肠道恶性肿瘤:倾向分数匹配分析

获取原文
获取原文并翻译 | 示例
           

摘要

Objectives This study was designed to assess the short- and long-term outcomes of gastric resection in cytoreductive surgery (CRS) and intraperitoneal chemotherapy (IPC) for lower gastrointestinal (GI) malignancies. Methods Patients with adenocarcinoma and appendiceal mucinous neoplasms were included. Redo and incomplete cytoreductions were excluded. A total of 756 patients were identified. Of these, 65 underwent gastric resection, 11 underwent wedge, 43 distal, and 11 subtotal and total gastrectomy. Preoperative differences were assessed for and addressed with matching. Perioperative outcomes, overall survival (OS), and risk-free survival (RFS) were assessed in two analyses: first all gastric resections were included and the second excluded wedge resections. Subgroup analysis according to diagnosis subtype was conducted. Results Demographic analysis revealed that markers of tumor aggression and poor nutrition were prevalent in the gastrectomy group. The matched analysis for gastric resections revealed higher rates of reoperation (38% vs. 22%, p = 0.028). After excluding wedge resections, increased rates of reoperation (40% vs. 22%, 0.019), grade 3/4 morbidity (76% vs. 59%, p = 0.036), and hospital stay (34 vs. 27 days, p = 0.012) were observed. For the unmatched cohort, OS (103 vs. 69 months, p = 0.501) and RFS (17 vs. 18 months, p = 0.181) for patients with CC = 0 were insignificantly different. In comparison for CC > 0, OS (31 vs. 83 months, p < 0.001) and RFS (9 vs. 20 months, p < 0.001) were significantly reduced in gastric resection. For the matched cohort, after excluding wedges, gastrectomy did not significantly decrease OS. However, RFS was decreased (11 vs. 20 months, p = 0.016). Conclusions Despite high postoperative morbidity, when complete cytoreduction is achieved, the need for gastric resection is not associated with inferior long-term outcomes.
机译:本研究的目标旨在评估细胞导致手术(CRS)和腹腔内化疗(IPC)中胃切除的短期和长期结果,用于低胃肠道(GI)恶性肿瘤。方法包括腺癌和阑尾粘液瘤的患者。没有排除重做和不完整的细胞功能。共发现了756名患者。其中,65次接受胃切除术,11个接受楔形,43个远端和11个小次特和总胃切除术。评估术前差异,并通过匹配来评估和解决。两次分析中评估了围手术期结果,总存活(OS)和无风险存活率(RFS):首先包括所有胃切除术,第二个排除楔切除术。根据诊断亚型进行亚组分析。结果人口统计分析显示胃切除术中肿瘤侵略性和营养差的标志物普遍存在。胃切除术的匹配分析揭示了更高的再捕获率(38%vs.22%,P = 0.028)。在排除楔形切除后,提高重组率(40%与22%,0.019),3/4级发病率(76%与59%,P = 0.036)和住院住宿(34 vs.27天,P =观察到0.012)。对于无与伦比的队列,OS(103对69个月,P = 0.501)和CC = 0患者的RFS(17 vs.18个月,P = 0.181)无关紧要。与CC> 0,OS(31对83个月,P <0.001)和RFS(9 vs.20个月,P <0.001)进行了显着降低。对于匹配的队列,在排除楔形后,胃切除术没有显着降低OS。然而,RFS减少(11,20个月,P = 0.016)。结论尽管术后发病率高,但在实现完全细胞辅助时,胃切除术的需求与劣质性的长期结果无关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号